Jove
Visualize
Contact Us

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

3.5K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Ablative Technologies for Thyroid Nodules: A Health Technology Assessment.

Ontario health technology assessment series·2026
Same journal

Paclitaxel-Coated Balloon Dilation for Adults With Recurrent Bulbar Urethral Stricture: A Health Technology Assessment.

Ontario health technology assessment series·2026
Same journal

Renal Denervation for Uncontrolled Hypertension: A Health Technology Assessment.

Ontario health technology assessment series·2026
Same journal

Home-Based Heated Humidified High-Flow Therapy for Respiratory Conditions: A Health Technology Assessment.

Ontario health technology assessment series·2025
Same journal

DNA Methylation-Based Classification for Central Nervous System Tumours: A Health Technology Assessment.

Ontario health technology assessment series·2025
Same journal

Percutaneous Vertebroplasty and Balloon Kyphoplasty for Painful Osteoporotic Vertebral Compression Fractures: A Health Technology Assessment.

Ontario health technology assessment series·2025
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 28, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.8K

Hepatitis C Screening: A Health Technology Assessment.

    Ontario Health Technology Assessment Series
    |February 26, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Expanding Hepatitis C virus (HCV) screening to all adults or the 1945-1975 birth cohort is more cost-effective and identifies more infections than risk-based screening alone. This approach can improve patient outcomes and reduce the burden of HCV.

    More Related Videos

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    2.7K
    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
    05:56

    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

    Published on: August 29, 2025

    607

    Related Experiment Videos

    Last Updated: Feb 28, 2026

    High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
    11:38

    High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

    Published on: May 10, 2016

    12.8K
    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    2.7K
    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
    05:56

    Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

    Published on: August 29, 2025

    607

    Area of Science:

    • Public Health
    • Hepatology
    • Health Technology Assessment

    Background:

    • Hepatitis C virus (HCV) infection can lead to severe liver disease, including cirrhosis, liver failure, and hepatocellular carcinoma (HCC).
    • Early detection through screening is crucial for linking infected individuals to care and treatment, preventing disease progression.
    • Current screening relies on risk-based approaches, potentially missing asymptomatic cases.

    Purpose of the Study:

    • To assess the effectiveness and cost-effectiveness of one-time universal HCV screening for all adults and for the 1945-1975 birth cohort, compared to risk-based screening alone.
    • To evaluate the budget impact of publicly funding expanded HCV screening programs in Ontario.
    • To understand patient preferences and values regarding HCV screening.

    Main Methods:

    • Systematic literature search for clinical evidence and patient preferences.
    • Risk of bias assessment using ROBINS-I and quality assessment using GRADE criteria.
    • Cost-utility analysis from a public payer perspective and budget impact analysis for Ontario over 5 years.

    Main Results:

    • One-time universal HCV screening may identify more cases and link more individuals to care, though evidence quality is very low.
    • Both universal screening strategies (all adults and 1945-1975 cohort) are less costly and more effective than risk-based screening alone.
    • Cost-effectiveness is high, with 100% probability at willingness-to-pay thresholds of $50,000-$100,000 per QALY gained.

    Conclusions:

    • Expanded one-time HCV screening offers a more effective and cost-effective strategy than risk-based screening alone.
    • Publicly funding universal screening in Ontario is projected to have significant budget implications over 5 years.
    • Patient perspectives highlight the need to broaden screening beyond high-risk groups for earlier diagnosis and treatment.